Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Cardiovascular Drugs and Therapy|October 14, 2022
RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart DiseaseMaria Birgaoanu, Marco Sachse, Aikaterini GatsiouCytokine|December 5, 2017
Platelet-derived chemokines in inflammation and atherosclerosisConstantinos Bakogiannis, Marco Sachse, Kimon Stamatelopoulos, et al.Antioxidants & Redox Signaling|August 2, 2017
Adenosine-to-Inosine RNA Editing in Health and DiseaseAikaterini Gatsiou, Nikolaos Vlachogiannis, Federica Francesca Lunella, et al.Atherosclerosis|February 9, 2023
RNA-binding proteins in vascular inflammation and atherosclerosisMarco Sachse, Simon Tual-Chalot, Giorgia Ciliberti, et al.Reviews in Cardiovascular Medicine|March 1, 2022
Circulating microRNAs in the prediction of BAV aortopathy: do the expression patterns correlate between blood and aortic tissue?Shiho Naito, Tatiana Sequeira-Gross, Johannes Petersen, et al.Journal of the American College of Cardiology|March 5, 2020
The Alzheimer's Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease: JACC Focus SeminarDimitrios A Stakos, Kimon Stamatelopoulos, Dimitrios Bampatsias, et al.Journal of Molecular and Cellular Cardiology|July 24, 2021
Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular diseaseNikolaos I Vlachogiannis, Marco Sachse, Georgios Georgiopoulos, et al.European Journal of Clinical Investigation|January 8, 2026
Amyloid-beta (1-40) peptide is associated with systemic metabolic healthKateryna Sopova, Dimitrios Delialis, Evmorfia Aivalioti, et al.The Journal of Clinical Endocrinology and Metabolism|September 11, 2024
Incremental Value of Blood-Based Markers of Liver Fibrosis in Cardiovascular Risk StratificationGeorgios Georgiopoulos, Stavros Athanasopoulos, Georgios Mavraganis, et al.European Journal of Clinical Investigation|February 24, 2025
Circulating amyloid beta 1-40 peptide as an associate of renal function declineGeorgios Mavraganis, Georgios Georgiopoulos, Georgios Zervas, et al.Pageof 2